San Diego, CA, United States of America

Dagmar Meissner


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Dagmar Meissner: Innovator in Biotechnological Advancements

Introduction

Dagmar Meissner is a notable inventor based in San Diego, California, recognized for his contributions to biotechnology through innovative research and development. With a portfolio of seven patents, Meissner has focused on enhancing the production processes of Sphingans, a type of polysaccharide with various applications in food and industrial products.

Latest Patents

Among his latest inventions is a groundbreaking patent that involves mutant bacterial strains of the genus Sphingomonas, specifically designed to be deficient in the production of polyhydroxybutyrate (PHB). This innovative process enables the mutant strains to generate PHB-deficient Sphingans. The patented process for preparing clarified Sphingan solutions entails heating aqueous Sphingan solutions to a specific temperature range of approximately 30°C to 70°C, followed by treatment with clarification agents and enzymes. This development is particularly significant as it leads to food or industrial products that incorporate PHB-deficient and/or clarified Sphingan, including a clarified, PHB-deficient high-acyl gellan and the associated manufacturing processes.

Career Highlights

Dagmar Meissner has made significant strides in the field of biotechnology while working for CP Kelco U.S., Inc. His research emphasizes the enhancement of microbial processes and product clarity, leading to greater sustainability and efficiency in product development.

Collaborations

Throughout his career, Meissner has collaborated with respected colleagues such as Stan Bower and Ellen Burke. These partnerships have facilitated the exchange of innovative ideas and expertise, contributing to the success of their research initiatives and the advancement of their respective projects.

Conclusion

Dagmar Meissner continues to be a prominent figure in the biotechnology landscape, with a focus on improving the production of valuable polysaccharides. His inventive spirit and commitment to innovation serve as an inspiration for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…